Somnus Therapeutics Raises $15 Million
Somnus Therapeutics Inc., a Bedminster, N.J.-based developer of a delayed-release sleep-maintenance therapy, has raised $15 million in Series A funding. CTI Life Sciences Fund led the round, and was joined by seed backer Care Capital.
11 February 2010•2 mins read
